STICE et al. V. STICE et al. V. STRELCHENKO et al. V. HENSEN et al. - Page 7




               F 40. Strelchenko Claims 106 and 107 were added by a preliminary amendment filed with the                                               
                        filing of the 09/357,445 on July 20, 1999. Strelchenko Application 09/357,445, Paper 2,                                        
                        p. 7.                                                                                                                          
               F 41. After multiple amendments, Strelchenko claim 106 was determined to be patentable by the                                           
                        examiner as involved Strelchenko Claim 106. Strelchenko claim 107 was cancelled by an                                          
                        amendment filed October 4,2000. Strelchenko Application 09/357,445, Paper filed October                                        
                        4, 2000 (designated as Paper 5, but listed as Paper 6 in the application contents), pp. I and                                  
                        3; Paper 10, p. 2.                                                                                                             
               F 42. Strelchenko Claim 48, original Claim 106 and Claim 107 were made prior to the critical date                                       
                        of August 31, 2000.                                                                                                            
               F 43. Strelchenko Claims 48, 106 and 107 each require nuclear transfer between a totipotent cell                                        
                        and an enucleated oocyte.                                                                                                      
               F 44. Strelchenko Claim 48 required using a totipotent cell as the donor material in nuclear                                            
                        transfer:                                                                                                                      
                                 48. A method forpreparing a cloned marmnalian embryo, comprising the                                                  
                                         step of a nuclear transfer between:                                                                           
                                         (a) a totipotent mammalian cell, wherein said cell is cultured and                                            
                                                  wherein said cell is not serum starved; and                                                          
                                         (b) an oocyte, wherein said oocyte is at a stage allowing                                                     
                                                  formation of said embryo.                                                                            
                        Strelchenko Application 09/357,445, Paper 1, specification, p. 96 (emphasis added).                                            
               F 45. Strelchenko Claims 106 and 107 also required use of a totipotent cell but further required                                        
                        that the totipotent cell be formed by reprogramming a non-embryonic cell:'                                                     
                                 106. A method for cloning an animal, comprising the steps of.                                                         
                                         (a) obtaining a non-embryonic cell from an animal;                                                            
                                         (b) reprogramming said non-embryonic cell to form a                                                           
                                                  Le.progarruned cell, wherein said reprouarnmed cell is                                               
                                                  totivoten ;                                                                                          
                                         (c) forming a cybrid by nuclear transfer of said reprogrammed                                                 
                                                  cell into an enucleated oocyte; and                                                                  

                                 Strelchenko's reproduction of Claim 106 on pages 21-22 Strelchenko's opposition (Paper 50) is not                     
               correct. The copy in the text above is the claim as it appears in the preliminary amendment filed July 20, 2000.                        
               Application 09/357,445, Paper 2, p. 7.                                                                                                  
                                                                       -7-                                                                             








Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007